Results 51 to 60 of about 40,122 (251)
Pharmacological Therapy for Fibrillations
Human beings suffer from two different kinds of fibrillations: one is atrial fibrillation (AF) and the other is ventricular fibrillation (VF). AF is the most common sustained arrhythmia and VF is the most serious.
Akira Fujiki, MD
doaj +1 more source
ABSTRACT Background Atrial tachycardias (AT) after radiofrequency ablation (RFA) of atrial fibrillation (AF) may utilize Bachmann's bundle (BB). Due to their epicardial location, these ATs remain poorly understood. Objective To describe the electrophysiologic and anatomic basis of BB‐related ATs.
Nate Christian‐Miller +10 more
wiley +1 more source
Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation [PDF]
Background: Based on its pharmacokinetic profile and electrophysiological effects in healthy horses, sotalol potentially could be used as a long-term PO antiarrhythmic drug in horses.
Anderson +31 more
core +2 more sources
ABSTRACT Background Cryoballoon ablation (CB) is a well‐established thermal technique for pulmonary vein isolation (PVI), while balloon‐in‐basket pulsed field ablation (BiB‐PFA) represents a novel non‐thermal alternative. Both single‐shot systems may trigger systemic inflammation and myocardial injury, yet direct comparisons are lacking.
Jan‐Per Wenzel +9 more
wiley +1 more source
Background Several different defibrillators are currently used for cardioversion and defibrillation of cardiac arrhythmias. The efficacy of a novel pulsed biphasic (PB) waveform has not been compared to other biphasic waveforms.
Anders S. Schmidt +9 more
doaj +1 more source
Background Electrical cardioversion (ECV) is routinely used to restore sinus rhythm in patients with symptomatic atrial fibrillation. The European guidelines have been updated in recent years.
Tomas Forslund +3 more
doaj +1 more source
Non-valvular atrial fibrillation and stroke : implications for management [PDF]
Nonvalvular Atrial Fibrillation is more prevalent with increasing age. It is associated with a six-fold excess risk of stroke; and a cumulative lifetime stroke risk of 35%. 15% of ischaemic strokes are directly attributable to it.
Tilney, Myra Kay
core
ABSTRACT Introduction There is limited data regarding the use of pulsed‐field ablation (PFA) for mitral isthmus (MI) ablation in patients with non‐paroxysmal atrial fibrillation (AF). Our aim was to assess the acute efficacy of MI ablation using a pentaspline PFA catheter with two different ablation settings.
Josef Hornof +13 more
wiley +1 more source
ABSTRACT Background EnSite X provides a module to filter oscillated generator impedance signals due to cardiac beating/respiration (averaged impedance drop, AID). TactiFlex ablation catheter Sensor Enabled (TFSE) is the latest product to incorporate a contact‐force sensor with a flexible tip but without lesion‐estimating parameters.
Masahide Harada +6 more
wiley +1 more source
Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation. [PDF]
: The optimal rhythm management strategy for people with non-paroxysmal (persistent or long-standing persistent) atrial fibrilation is currently not well defined. Antiarrhythmic drugs have been the mainstay of therapy.
Adler, AJ +8 more
core +3 more sources

